tirzepatide testing Ixekizumab Plus Outperforms Biologic Monotherapy Tirzepatide vs. Semaglutide For Weight

Taheri, S., Gasparovic, C., Shah, N

Funding Authors declare no funding for this work

As long as we uphold safety, transparency, and evidence-based practice, there is roomand reasonto apply these therapies thoughtfully, even beyond traditional BMI thresholds

Retatrutide is being studied in phase 3 clinical trials following promising phase 2 results for weight reduction and metabolic improvement in adults with obesity, but it is not available through NHS prescribing pathways

Headaches and dizziness Headaches occur in approximately 14% of semaglutide users and at similar rates with tirzepatide

Rather than assuming temporary disruption, it's important to systematically assess sleep symptoms and discuss them with your healthcare provider